Market Cap 11.16B
Revenue (ttm) 2.52B
Net Income (ttm) 102.98M
EPS (ttm) N/A
PE Ratio 23.72
Forward PE 22.28
Profit Margin 4.09%
Debt to Equity Ratio 0.00
Volume 1,422,000
Avg Vol 1,729,632
Day's Range N/A - N/A
Shares Out 133.84M
Stochastic %K 56%
Beta 1.15
Analysts Strong Sell
Price Target $90.00

Company Profile

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 930 1800
Address:
2560 General Armistead Avenue, Audubon, United States
PrivateProfiteering
PrivateProfiteering Nov. 21 at 3:12 AM
$GMED is currently trading at $82.28 with an RSI of 84.13, indicating it is in overbought territory, which suggests a potential price correction may be imminent. The price is significantly above the 30-day moving average (MA30) of 68.55 and the 50-day moving average (MA50) of 64.21, reinforcing the notion of overextension. The recent high of $87.16 and low of $54.15 over the past 60 days further illustrate a volatile range, with the current price nearing the upper end. Market context suggests caution due to the high RSI and proximity to the recent high. A suggested entry point could be around $80.00 if a pullback occurs. Set a stop loss at $78.00 to manage risk. For targets, consider $85.00 as the first target, with a secondary target at $87.00, aligning with the recent high. Overall, the trade plan is to watch for a pullback to enter short-term, while being mindful of the overbought conditions. https://privateprofiteers.com
0 · Reply
Iightning
Iightning Nov. 21 at 12:41 AM
1ightning® Options Trade Alert (Actionable) | Buy $GMED Dec 19 $85 Call | Enter: $2.58 Exit: $3.40 | Profit: 31.69% ROI | https://1ightning.com
0 · Reply
PrivateProfiteering
PrivateProfiteering Nov. 20 at 8:30 AM
$GMED is currently experiencing a strong bullish momentum, closing at $84.45 with an RSI of 83.14, indicating overbought conditions. The 30-day moving average (MA30) at $65.43 and the 50-day moving average (MA50) at $62.28 suggest a robust upward trend, as the price is significantly above these averages. Given the recent 60-day high of $87.16, there is potential for further upside, but caution is warranted due to the high RSI. A pullback could occur before any significant breakout. Suggested entry is at $83.00 to account for potential retracement. Set a stop loss at $80.00 to limit downside risk. Target 1 is $87.00, near the 60-day high, while Target 2 is $90.00, allowing for further upside if momentum continues. Monitor price action closely, as the high RSI may lead to volatility. https://privateprofiteers.com
0 · Reply
Iightning
Iightning Nov. 19 at 10:13 PM
1ightning® Options Trade Alert (Actionable) | Buy $GMED Dec 19 $85 Call | Enter: $2.58 Exit: $3.40 | Profit: 31.69% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 6:35 AM
1ightning® Options Trade Alert (Actionable) | Buy $GMED Dec 19 $85 Call | Enter: $2.58 Exit: $3.40 | Profit: 31.69% ROI | https://1ightning.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 18 at 1:36 PM
Truist Securities has updated their rating for Globus Medical ( $GMED ) to Buy with a price target of 105.
0 · Reply
nauristreigys
nauristreigys Nov. 13 at 12:54 PM
$GMED Buy&Hold. For more information visit my site. Investment Scoreboard
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 6:47 PM
Barclays updates rating for Globus Medical ( $GMED ) to Overweight, target set at 106 → 114.
0 · Reply
IN0V8
IN0V8 Nov. 10 at 5:29 PM
$GMED buy Barclays raises target price to $114 from $106
0 · Reply
BioTechHealthX
BioTechHealthX Nov. 9 at 6:52 AM
$GMED With $2.X.9 B full-year target & new robotics innovations, Globus Medical cements leadership in spine & trauma devices. Click here to know more! https://biotechhealthx.com/biotech-news/globus-medical-gmed-raises-2025-revenue-guidance-to-2-9-b-heres-what-it-means/
0 · Reply
Latest News on GMED
Globus Medical: Straightening Its Back

Nov 11, 2025, 10:00 AM EST - 9 days ago

Globus Medical: Straightening Its Back


Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 9:56 PM EST - 14 days ago

Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript


Globus Medical Reports Third Quarter 2025 Results

Nov 6, 2025, 4:15 PM EST - 14 days ago

Globus Medical Reports Third Quarter 2025 Results


Is Wall Street Underestimating Globus Medical Stock's Potential?

Oct 22, 2025, 11:25 AM EDT - 4 weeks ago

Is Wall Street Underestimating Globus Medical Stock's Potential?


Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:05 PM EDT - 3 months ago

Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript


Globus Medical Reports Second Quarter 2025 Results

Aug 7, 2025, 4:15 PM EDT - 3 months ago

Globus Medical Reports Second Quarter 2025 Results


Globus Medical: Obtaining My Backing Again

Jul 3, 2025, 12:10 PM EDT - 5 months ago

Globus Medical: Obtaining My Backing Again


Globus Medical Announces $500 Million Share Repurchase Program

May 15, 2025, 4:30 PM EDT - 6 months ago

Globus Medical Announces $500 Million Share Repurchase Program


Medical, Inc. Company Investigated by the Portnoy Law Firm

May 13, 2025, 6:28 PM EDT - 6 months ago

Medical, Inc. Company Investigated by the Portnoy Law Firm


Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:32 PM EDT - 7 months ago

Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript


Globus Medical Reports First Quarter 2025 Results

May 8, 2025, 4:15 PM EDT - 7 months ago

Globus Medical Reports First Quarter 2025 Results


Globus Medical completes acquisition of Nevro Corp.

Apr 3, 2025, 8:31 AM EDT - 8 months ago

Globus Medical completes acquisition of Nevro Corp.


Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 9:54 PM EST - 9 months ago

Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript


Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Feb 20, 2025, 4:15 PM EST - 9 months ago

Globus Medical Reports Fourth Quarter and Full Year 2024 Results


Top 2 Health Care Stocks That May Crash In February

Feb 5, 2025, 6:57 AM EST - 10 months ago

Top 2 Health Care Stocks That May Crash In February

OFIX


PrivateProfiteering
PrivateProfiteering Nov. 21 at 3:12 AM
$GMED is currently trading at $82.28 with an RSI of 84.13, indicating it is in overbought territory, which suggests a potential price correction may be imminent. The price is significantly above the 30-day moving average (MA30) of 68.55 and the 50-day moving average (MA50) of 64.21, reinforcing the notion of overextension. The recent high of $87.16 and low of $54.15 over the past 60 days further illustrate a volatile range, with the current price nearing the upper end. Market context suggests caution due to the high RSI and proximity to the recent high. A suggested entry point could be around $80.00 if a pullback occurs. Set a stop loss at $78.00 to manage risk. For targets, consider $85.00 as the first target, with a secondary target at $87.00, aligning with the recent high. Overall, the trade plan is to watch for a pullback to enter short-term, while being mindful of the overbought conditions. https://privateprofiteers.com
0 · Reply
Iightning
Iightning Nov. 21 at 12:41 AM
1ightning® Options Trade Alert (Actionable) | Buy $GMED Dec 19 $85 Call | Enter: $2.58 Exit: $3.40 | Profit: 31.69% ROI | https://1ightning.com
0 · Reply
PrivateProfiteering
PrivateProfiteering Nov. 20 at 8:30 AM
$GMED is currently experiencing a strong bullish momentum, closing at $84.45 with an RSI of 83.14, indicating overbought conditions. The 30-day moving average (MA30) at $65.43 and the 50-day moving average (MA50) at $62.28 suggest a robust upward trend, as the price is significantly above these averages. Given the recent 60-day high of $87.16, there is potential for further upside, but caution is warranted due to the high RSI. A pullback could occur before any significant breakout. Suggested entry is at $83.00 to account for potential retracement. Set a stop loss at $80.00 to limit downside risk. Target 1 is $87.00, near the 60-day high, while Target 2 is $90.00, allowing for further upside if momentum continues. Monitor price action closely, as the high RSI may lead to volatility. https://privateprofiteers.com
0 · Reply
Iightning
Iightning Nov. 19 at 10:13 PM
1ightning® Options Trade Alert (Actionable) | Buy $GMED Dec 19 $85 Call | Enter: $2.58 Exit: $3.40 | Profit: 31.69% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 6:35 AM
1ightning® Options Trade Alert (Actionable) | Buy $GMED Dec 19 $85 Call | Enter: $2.58 Exit: $3.40 | Profit: 31.69% ROI | https://1ightning.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 18 at 1:36 PM
Truist Securities has updated their rating for Globus Medical ( $GMED ) to Buy with a price target of 105.
0 · Reply
nauristreigys
nauristreigys Nov. 13 at 12:54 PM
$GMED Buy&Hold. For more information visit my site. Investment Scoreboard
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 6:47 PM
Barclays updates rating for Globus Medical ( $GMED ) to Overweight, target set at 106 → 114.
0 · Reply
IN0V8
IN0V8 Nov. 10 at 5:29 PM
$GMED buy Barclays raises target price to $114 from $106
0 · Reply
BioTechHealthX
BioTechHealthX Nov. 9 at 6:52 AM
$GMED With $2.X.9 B full-year target & new robotics innovations, Globus Medical cements leadership in spine & trauma devices. Click here to know more! https://biotechhealthx.com/biotech-news/globus-medical-gmed-raises-2025-revenue-guidance-to-2-9-b-heres-what-it-means/
0 · Reply
RonIsWrong
RonIsWrong Nov. 7 at 10:07 PM
$GMED I'm very happy with the trade. Had I held, I could have wrangled another $1-2, but I took the win right away. Interestingly, the big trade that tipped me off was a 15 dollar wide call spread, which they bought for $2. Looks like they booked $12.30 profit in total on that, which is outstanding. My profit was $14.85 because I didn't have a short leg.
0 · Reply
Neo83
Neo83 Nov. 7 at 9:35 PM
$GMED this one also paid 💪🏻 💰
0 · Reply
Victory777777
Victory777777 Nov. 7 at 9:27 PM
$GMED next week will be $BYND ’s turn
0 · Reply
topstockalerts
topstockalerts Nov. 7 at 9:12 PM
Top Gainers PT2 $CHEK $GMED $KODK $HLLY $NATR
0 · Reply
DennBillions
DennBillions Nov. 7 at 8:46 PM
$GMED it is time for this pump to collapse inward on itself lgi
0 · Reply
DennBillions
DennBillions Nov. 7 at 8:35 PM
$GMED $BBGI this bot campaign needs to be removed from stocktwits for bbgi
0 · Reply
DennBillions
DennBillions Nov. 7 at 8:30 PM
$GMED time to deleverage boys
0 · Reply
Deepit
Deepit Nov. 7 at 8:22 PM
$GMED Something tells me this is going to drop like hell!
0 · Reply
CowBoE
CowBoE Nov. 7 at 8:20 PM
$RAY.X $MSGM $ORGO $HLLY $GMED Your top Nasdaq % gainers. Lucky you if have happened to have them. I have only few of them USAMY ABAT EXPE.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 7:07 PM
RBC Capital updates rating for Globus Medical ( $GMED ) to Outperform, target set at 88 → 92.
0 · Reply
topstockalerts
topstockalerts Nov. 7 at 6:53 PM
$GMED showing high relative strength.. Stay tuned for more!
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 6:52 PM
Wells Fargo has updated their rating for Globus Medical ( $GMED ) to Overweight with a price target of 79.
0 · Reply